Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MSA-C”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Not applicableLooking for participantsNCT06647641
What this trial is testing

The CurePSP Genetics Program

Who this might be right for
PSPPSP - Progressive Supranuclear PalsyCorticobasal Syndrome+17 more
Massachusetts General Hospital 1,000
Not applicableLooking for participantsNCT06821256
What this trial is testing

Efficacy and Safety of Transcranial dIrect Current stiMulation in Multiple System Atrophy-Cerebellar Variant

Who this might be right for
Multiple System Atrophy - Cerebellar Subtype (MSA-C)
University of Salerno 30
Testing effectiveness (Phase 2)Study completedNCT00038610
What this trial is testing

Study of Hyper-CVAD Plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 54
Not applicableNo Longer AvailableNCT05086094
What this trial is testing

Expanded Access Protocol of Verdiperstat in Patients With Multiple System Atrophy (MSA)

Who this might be right for
Multiple System Atrophy (MSA)
Biohaven Pharmaceuticals, Inc.
Not applicableStudy completedNCT02035761
What this trial is testing

PET Imaging Study of Neurochemical and Autonomic Disorders in Multiple System Atrophy (MSA)

Who this might be right for
Multiple System Atrophy - Parkinsonian Subtype (MSA-P)Multiple System Atrophy - Cerebellar Subtype (MSA-C)
University of Michigan 23
Not applicableStudy completedNCT05557786
What this trial is testing

Treatment of Transcranial Alternating Current Stimulation（tACS）on Cerebellar Ataxia

Who this might be right for
Spinocerebellar Ataxia Type 3Multiple System Atrophy-cerebellar Type
First Affiliated Hospital of Fujian Medical University 164
Testing effectiveness (Phase 2)Study completedNCT01083342
What this trial is testing

High-Dose (HD) Methotrexate (MTX) Induction Chemotherapy Followed by Alternative HD MTX-based and HD Cytarabine-based Combination Consolidation Chemotherapy for Newly Diagnosed Primary CNS Lymphoma; CISL 10-01 Study

Who this might be right for
CNS Lymphoma
Samsung Medical Center 36
Not applicableLooking for participantsNCT06890377
What this trial is testing

Targeted Α-synuclein PET Imaging in the Diagnosis of Multiple System Atrophy

Who this might be right for
Multiple System Atrophy - Cerebellar Subtype (MSA-C)Multiple System Atrophy - Parkinsonian Subtype (MSA-P)
Min Zhao,MD 90
Not applicableLooking for participantsNCT06890390
What this trial is testing

TSPO PET in the Evaluation of Neuroinflammation in Patients with Multiple System Atrophy

Who this might be right for
Multiple System Atrophy - Cerebellar Subtype (MSA-C)Multiple System Atrophy - Parkinsonian Subtype (MSA-P)
Min Zhao,MD 90
Testing effectiveness (Phase 2)Ended earlyNCT00997672
What this trial is testing

Lithium in Multiple System Atrophy

Who this might be right for
Multiple System Atrophy
Federico II University 10
Testing effectiveness (Phase 2)Study completedNCT00290433
What this trial is testing

Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 55
Large-scale testing (Phase 3)Active Not RecruitingNCT03408080
What this trial is testing

Open Pilot Trial of BHV-4157

Who this might be right for
Spinocerebellar AtaxiasSpinocerebellar Ataxia Type 1Spinocerebellar Ataxia Type 2+3 more
University of California, Los Angeles 24